{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
M005
(2025)
Source URL:
First approved in 1988
Source:
ANDA089525
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
First approved in 1988
Source:
21 CFR 348
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2011)
Source URL:
First approved in 1988
Source:
21 CFR 333E
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2001)
Source URL:
First approved in 1987
Source:
NDA019625
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA076558
(1987)
Source URL:
First approved in 1987
Source:
ANDA076558
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA019258
(1986)
Source URL:
First approved in 1986
Source:
NDA019258
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA019258
(1986)
Source URL:
First approved in 1986
Source:
NDA019258
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2013)
Source URL:
First approved in 1985
Source:
ANDA210497
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
LorMate by Redmont Pharmacetuicals, LLC
(2020)
Source URL:
First approved in 1984
Source:
NDA017532
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA209351
(1984)
Source URL:
First approved in 1984
Source:
ANDA209351
Source URL:
Class:
MIXTURE